Form 4: LeMaitre Vascular CEO George W. LeMaitre Reports Stock Transactions

LeMaitre Vascular's CEO, George W. LeMaitre, reports the acquisition of 32 shares and the disposal of 298 shares of common stock on December 2, 2024, related to dividend equivalent rights and tax obligations.

Summary

• George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, reported transactions involving the company's common stock on December 2, 2024.
• He acquired 32 shares of common stock at $0 per share due to the release of dividend equivalent rights.
• He also disposed of 298 shares at $105.47 per share to cover tax withholding obligations related to previously vested restricted stock units.
• Following these transactions, Mr. LeMaitre beneficially owns 1,889,188 shares of LeMaitre Vascular common stock.

Sentiment

Score: 7

Explanation: The document reflects standard executive stock transactions, which are neither particularly positive nor negative. The sentiment is neutral to slightly positive due to the acquisition of shares through dividend equivalent rights.

Positives

• The acquisition of shares through dividend equivalent rights indicates a return of value to the executive.

Negatives

• The disposal of shares to cover tax obligations, while standard, reduces the executive's overall holdings.

Risks

• There are no significant risks identified in this document.

Industry Context

This is a routine filing related to executive stock transactions and is common practice for publicly traded companies. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The transactions are typical for executives who receive stock-based compensation, such as restricted stock units and dividend equivalent rights.
• The tax withholding process is a common practice to cover tax liabilities associated with vesting of stock awards.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.

Key Dates

Keywords

LeMaitre Vascular, George W. LeMaitre, stock transaction, Form 4, insider trading, dividend equivalent rights, restricted stock units, tax withholding